TBPH
Theravance Biopharma Inc
Price:  
8.48 
USD
Volume:  
301,747.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH EV/EBITDA

-150.9%
Upside

As of 2024-06-17, the EV/EBITDA ratio of Theravance Biopharma Inc (TBPH) is -7.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TBPH's latest enterprise value is 312.41 mil USD. TBPH's TTM EBITDA according to its financial statements is -39.34 mil USD. Dividing these 2 quantities gives us the above TBPH EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.1x - 8.4x 6.8x
Forward P/E multiples 5.1x - 11.5x 9.0x
Fair Price (2.05) - (4.76) (4.32)
Upside -124.2% - -156.1% -150.9%
8.48 USD
Stock Price
(4.32) USD
Fair Price

TBPH EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-17 -7.88
2024-06-14 -7.94
2024-06-13 -8.06
2024-06-12 -8.14
2024-06-11 -8.36
2024-06-10 -8.21
2024-06-07 -8.30
2024-06-06 -8.43
2024-06-05 -8.56
2024-06-04 -8.13
2024-06-03 -8.00
2024-05-31 -8.11
2024-05-30 -7.95
2024-05-29 -7.71
2024-05-28 -7.85
2024-05-24 -7.77
2024-05-23 -8.03
2024-05-22 -8.56
2024-05-21 -8.73
2024-05-20 -8.71
2024-05-17 -8.94
2024-05-16 -9.32
2024-05-15 -9.63
2024-05-14 -9.07
2024-05-13 -9.30
2024-05-10 -9.05
2024-05-09 -9.16
2024-05-08 -9.19
2024-05-07 -9.25
2024-05-06 -9.32
2024-05-03 -9.15
2024-05-02 -9.04
2024-05-01 -8.39
2024-04-30 -7.89
2024-04-29 -8.57
2024-04-26 -8.73
2024-04-25 -8.76
2024-04-24 -8.79
2024-04-23 -8.86
2024-04-22 -9.15
2024-04-19 -9.00
2024-04-18 -8.83
2024-04-17 -9.23
2024-04-16 -9.44
2024-04-15 -9.72
2024-04-12 -9.34
2024-04-11 -8.50
2024-04-10 -9.25
2024-04-09 -9.18
2024-04-08 -9.16